HZ-A-018, a novel inhibitor of Bruton tyrosine kinase, exerts anti-cancer activity and sensitizes 5-FU in gastric cancer cells
Gastric cancer is the third leading cause of cancer related death worldwide. Due to the complexity and heterogeneity of gastric cancer, the development of targeted drugs is somehow limited, but is urgently needed. Since the expression of Bruton tyrosine kinase (BTK) was significantly associated with...
Saved in:
Main Authors: | Danjing Liu (Author), Wei Xu (Author), Bin Lin (Author), Cong Ji (Author), Minmin Shen (Author), Shuying Shen (Author), Junjie Ma (Author), Xinglu Zhou (Author), Youyou Yan (Author), Bo Zhang (Author), Nengming Lin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A phase 1 study of dimdazenil to evaluate the pharmacokinetics, food effect and safety in Chinese healthy subjects
by: Fei Wang, et al.
Published: (2023) -
Discovery of potential WEE1 inhibitors via hybrid virtual screening
by: Tingting Jin, et al.
Published: (2023) -
S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1
by: Yasi Xu, et al.
Published: (2018) -
Recent progress of ferroptosis in cancers and drug discovery
by: Xiang Wang, et al.
Published: (2024) -
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China
by: Changcheng Shi, et al.
Published: (2022)